Liquid biopsy for chondrosarcoma patients
Part of Cancer clinical trials.
This trial tests whether a simple blood test (liquid biopsy) can help monitor chondrosarcoma, a type of cartilage cancer. It may offer a less invasive way to track the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of cartilage tumor that is semi-malignant or malignant (such as atypical cartilaginous tumor or chondrosarcoma grade 1, 2, or 3)
- You have had surgery to remove the main tumor
- You have not had any cancer treatments other than a biopsy before joining this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a liquid biopsy (a simple blood test that looks for cancer DNA) to decide whether you should have chemotherapy before surgery or go straight to surgery. It is for people with pancreatic cancer that has not spread beyond the pancreas.
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
This study is looking at different types of cartilage tumors to find better ways to diagnose and treat them. If you have a confirmed cartilage tumor, you may be able to join and help researchers learn more about your condition.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This trial studies why people with chondrosarcoma choose to join or not join clinical trials. It collects information through regular electronic reports to improve future cancer research.
This trial is testing a blood test (liquid biopsy) to look for tiny traces of cancer DNA after surgery for pancreatic cancer. It may help doctors understand if the cancer is likely to come back.
Hear when a new Chondrosarcoma of the Bone trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.